SupremeToday Landscape Ad

AI Overview

AI Overview...

  • Cough Syrup Containing Codeine and NDPS Act Applicability Several judgments indicate that whether syrup containing codeine falls under the NDPS Act depends on specific circumstances, including its classification as a narcotic drug, whether it is manufactured or used for therapeutic purposes, and its inclusion in official notifications. For instance, the High Court in Himachal Pradesh has referred the question of whether such syrups are 'manufactured drugs' under the NDPS Act to a larger bench, highlighting the complexity of classification (Deepak Rawat vs. State of H.P., 2024) SHUVAM SHUKLA vs STATE OF HP - Himachal Pradesh, and similar considerations are discussed in other cases Mohd Ahsan VS Customs - Delhi, Mohd. Ahsan vs Customs - Delhi.

  • Exemptions and Therapeutic Use Some courts have held that cough syrups containing codeine, when used for legitimate medicinal purposes and obtained from licensed manufacturers or stockists, may fall within exceptions under Entry 35 of the Notification dated 14-11-1985, thus not attracting NDPS provisions. The judgment in Hemant Kumar Saini (2021) emphasizes that possession of such syrups with licensed stockists may not invoke penalties under the NDPS Act Vibhor Rana VS Union of India - Allahabad.

  • Classification as Narcotic or Manufactured Drug A key issue is whether codeine-based syrups are considered narcotic drugs under the NDPS Act. While some courts have taken the view that these syrups are used therapeutically and thus not narcotic, others have noted the need to examine whether they qualify as 'manufactured drugs' under the Act. The distinction is crucial because it affects applicability of the NDPS provisions, especially regarding quantities and penalties Raghav Saini VS State of Himachal Pradesh - Himachal Pradesh, Mohd Ahsan VS Customs - Delhi.

  • Quantitative Considerations and Quantity Thresholds Courts have discussed whether the quantity of codeine in seized syrups constitutes a 'small' or 'commercial' quantity, impacting bail and sentencing. For example, in one case, the seizure of 98 bottles containing 9.8 grams of codeine was argued to be a small quantity, thus not invoking the harsher provisions of the NDPS Act Mukesh Kumar VS State of Bihar - Patna.

  • Legal and Regulatory Framework The Drugs and Cosmetics Act, along with the NDPS Act, governs the regulation of such syrups, with some judgments emphasizing that possession or manufacture under licensed conditions may exempt from NDPS penalties. The legal debate continues regarding whether syrup containing codeine, especially when used medicinally, should be classified as a narcotic drug under the NDPS Act Ramraj Choudhury VS State Of West Bengal - Calcutta, Login Das @ Lagin Rabi Das VS State of West Bengal - Calcutta.

Analysis and ConclusionThe recent judicial landscape reveals that the classification of syrup containing codeine under the NDPS Act is nuanced. When used for legitimate medicinal purposes and obtained from licensed sources, such syrups may be exempt from NDPS provisions, especially if they fall within notified exceptions. However, in cases where the syrup is seized without proper licensing or for non-medicinal purposes, courts tend to treat them as narcotic or manufactured drugs, invoking NDPS provisions. The question of whether such syrups fall under the NDPS Act is currently under judicial consideration and may vary depending on specific facts, quantities, and regulatory compliance. The courts are also deliberating on whether these products qualify as 'manufactured drugs' under the Act, with some judgments suggesting they do not when used therapeutically SHUVAM SHUKLA vs STATE OF HP - Himachal Pradesh, Vibhor Rana VS Union of India - Allahabad.

References:- SADDAM HUSSAIN vs STATE OF CHHATTISGARH - Chhattisgarh- Ravi Patel vs The State Of Madhya Pradesh - 2024 Supreme(Online)(MP) 7409 - 2024 Supreme(Online)(MP) 7409- Login Das @ Lagin Rabi Das VS State of West Bengal - Calcutta- Raghav Saini VS State of Himachal Pradesh - Himachal Pradesh- Mukesh Kumar VS State of Bihar - Patna- Ramraj Choudhury VS State Of West Bengal - Calcutta- Vibhor Rana VS Union of India - Allahabad- Mohd Ahsan VS Customs - Delhi- Mohd. Ahsan vs Customs - Delhi

Codeine Syrup under NDPS Act: MP HC's Recent Ruling

In the realm of pharmaceutical regulations and narcotics control, one pressing question has sparked significant judicial scrutiny: Recent MP HC Judgment Whether Syrup Containing Codeine Falls under NDPS Act. Cough syrups like Phensedyl, containing codeine phosphate, are commonly used for therapeutic purposes, yet their possession in large quantities often leads to NDPS Act charges. This blog delves into the nuances of the Madhya Pradesh High Court's (MP HC) recent judgment, key precedents, and regulatory frameworks to clarify when such syrups attract NDPS penalties.

The Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985, strictly regulates narcotic drugs and psychotropic substances. However, codeine-based cough syrups occupy a gray area, balancing medicinal utility under the Drugs and Cosmetics Act against potential abuse. Recent rulings emphasize context—quantity, licensing, and intent—as pivotal factors. This analysis draws from authoritative judgments to provide clarity, though it is for informational purposes only and not a substitute for professional legal advice.

Key Findings from the MP HC Judgment

The MP HC meticulously examined the classification of cough syrups containing codeine phosphate. Central to the ruling was the definition of a manufactured drug under the NDPS Act. The court held that syrups produced by licensed manufacturers and adhering to prescribed codeine limits do not qualify as narcotic drugs under the Act. Rohit Chadha VS State of Madhya Pradesh - Madhya Pradesh (2015)Ashok Kumar Thru (Brother) Rakesh Kumar Pawar VS Union of India Thru Ministry of Home New Delhi - Allahabad (2014)

This distinction underscores that not all codeine-containing syrups are inherently narcotic; regulatory compliance is key.

Legal Precedents Shaping the Debate

Judicial interpretations have evolved, with several High Courts weighing in. The Allahabad High Court in Ashok Kumar Vs. Union of India ruled that possession of Phensedyl by licensed stockists within limits does not attract NDPS penalties. Arvind Kumar vs State - Delhi (2020)Arvind Kumar VS State Through the Inspector, Central Bureau of Narcotics - Delhi (2020)

Similarly, in a Chhattisgarh High Court case, 47 pieces of Rax Cough Syrup containing codeine were scrutinized, with Section 37 of the NDPS Act invoked due to commercial quantity. The court noted: codene – which comes within the commercial quantity, was seized from the applicant. SADDAM HUSSAIN vs STATE OF CHHATTISGARH - Chhattisgarh

In Madhya Pradesh, a case involving two boxes of 240 bottles of S-KUF-Codeine Phosphate syrup (100 ml each) led to charges under Sections 8, 21, and 22 of the NDPS Act. Ravi Patel vs The State Of Madhya Pradesh - 2024 Supreme(Online)(MP) 7409

The Himachal Pradesh High Court referred the issue of whether such syrups are 'manufactured drugs' to a larger bench in Deepak Rawat vs. State of H.P. (2024), highlighting ongoing complexity. SHUVAM SHUKLA vs STATE OF HP - Himachal Pradesh Courts like in Hemant Kumar Saini (2021) affirmed exemptions for licensed possession under Notification Entry 35 dated 14-11-1985. Vibhor Rana VS Union of India - Allahabad

Another precedent quashed proceedings, holding: Phensedyl Cough Syrup falls within the exception provided under the NDPS Act and therefore its possession with licenced stockists should not invite the penalties under the NDPS Act... no offence under Section 8/21 read with Section - 29 NDPS Act is made out. Manoj Kumar Bhuyan And Other VS State Of Orissa - 2021 Supreme(Ori) 168 - 2021 0 Supreme(Ori) 168

Commercial Quantity and Quantitative Analysis

Determining commercial vs. small quantity is crucial for bail, sentencing, and penalties. The MP HC stressed evaluating total syrup weight alongside narcotic content. Iqbal Singh VS State - Delhi (2020)Ehsad Ansari VS State of M. P. - Madhya Pradesh (2021)

Courts consistently direct weighing pure codeine content against neutral syrup base for threshold calculations. Raghav Saini VS State of Himachal Pradesh - Himachal PradeshMohd Ahsan VS Customs - Delhi

Regulatory Framework: NDPS Act vs. Drugs and Cosmetics Act

Codeine syrups are governed dually:

Notifications like the 1985 Entry 35 provide carve-outs, yet misuse—evidenced by diversion—nullifies exemptions. The debate persists: Are these 'narcotic drugs' or mere 'manufactured drugs'? Therapeutic intent typically shields compliant parties. Mohd. Ahsan vs Customs - Delhi

Practical Implications and Compliance Tips

For pharmacists, stockists, and consumers:

  • Maintain Documentation: Licenses, invoices, and prescriptions prove therapeutic use.
  • Monitor Quantities: Adhere to NDPS-prescribed limits to avoid commercial quantity tags.
  • Avoid Diversion Risks: Large, unlicensed holdings invite scrutiny.

Legal practitioners must assess facts holistically—quantity, source, and purpose—before NDPS applicability. Mohd Ahsan VS Customs - Delhi

Conclusion and Key Takeaways

The MP HC's judgment clarifies that cough syrups containing codeine may not fall under the NDPS Act if within limits, licensed, and for therapeutic use. However, excesses or misuse trigger penalties. This nuanced stance aligns with precedents emphasizing context over blanket classification.

Key Takeaways:- Licensed, limited possession generally exempt. Ashok Kumar Thru (Brother) Rakesh Kumar Pawar VS Union of India Thru Ministry of Home New Delhi - Allahabad (2014)- Commercial quantities (e.g., thousands of bottles) invoke NDPS. Fantoosh Yadav VS State (Govt. of NCT of Delhi) - Delhi (2022)- Courts favor exemptions for medicinal compliance. Manoj Kumar Bhuyan And Other VS State Of Orissa - 2021 Supreme(Ori) 168 - 2021 0 Supreme(Ori) 168- Ongoing referrals signal evolving jurisprudence. SHUVAM SHUKLA vs STATE OF HP - Himachal Pradesh

Ensure dual compliance with NDPS and Drugs Acts. Consult legal experts for case-specific guidance—this post offers general insights only.

References: Rohit Chadha VS State of Madhya Pradesh - Madhya Pradesh (2015)Ashok Kumar Thru (Brother) Rakesh Kumar Pawar VS Union of India Thru Ministry of Home New Delhi - Allahabad (2014)Fantoosh Yadav VS State (Govt. of NCT of Delhi) - Delhi (2022)Arvind Kumar vs State - Delhi (2020)Arvind Kumar VS State Through the Inspector, Central Bureau of Narcotics - Delhi (2020)Iqbal Singh VS State - Delhi (2020)Ehsad Ansari VS State of M. P. - Madhya Pradesh (2021)Aasif Ishtiyaq VS State of J&K - J&K (2017)SADDAM HUSSAIN vs STATE OF CHHATTISGARH - ChhattisgarhRavi Patel vs The State Of Madhya Pradesh - 2024 Supreme(Online)(MP) 7409Shavinderpal VS State of Punjab - 2024 Supreme(P&H) 1290 - 2024 0 Supreme(P&H) 1290Manoj Kumar Bhuyan And Other VS State Of Orissa - 2021 Supreme(Ori) 168 - 2021 0 Supreme(Ori) 168SHUVAM SHUKLA vs STATE OF HP - Himachal PradeshVibhor Rana VS Union of India - AllahabadRaghav Saini VS State of Himachal Pradesh - Himachal PradeshMukesh Kumar VS State of Bihar - PatnaRamraj Choudhury VS State Of West Bengal - CalcuttaLogin Das @ Lagin Rabi Das VS State of West Bengal - CalcuttaMohd Ahsan VS Customs - DelhiMohd. Ahsan vs Customs - Delhi

#NDPSAct, #CodeineSyrup, #LegalRuling
Chat Download
Chat Print
Chat R ALL
Landmark
Strategy
Argument
Risk
Chat Voice Bottom Icon
Chat Sent Bottom Icon
SupremeToday Portrait Ad
logo-black

An indispensable Tool for Legal Professionals, Endorsed by Various High Court and Judicial Officers

Please visit our Training & Support
Center or Contact Us for assistance

qr

Scan Me!

India’s Legal research and Law Firm App, Download now!

For Daily Legal Updates, Join us on :

whatsapp-icon telegram-icon
whatsapp-icon Back to top